
GliSODin: melasma treatment is 3 times more effective
There are encouraging data on the treatment of melasma with systemic drugs.
Melasma is a common problem and predominantly affects women. It manifests itself in the form of confluent hyperpigmentation on the face with predominant localization in the cheekbones and forehead.
3 times more effective treatment for melasma
A promising in melasma treatments is the use of systemic drugs in the complex treatment of melasma. IsoCell presents encouraging clinical trials for the treatment of melasma.

A double-blind, placebo-controlled study was conducted in 47 patients with melasma for 12 weeks. The results of the study showed that the classical treatment regimen for melasma with the combination of hydroquinone with retinol and a hormonal agent showed an effectiveness of 23%. In the group of patients who, in addition to the main treatment, took GliSODin, the severity of melasma decreased by 68%, which is 3 times more effective compared to treatment with hydroquinone with retinol.
GliSODin allows you to increase the effectiveness of melasma treatment 3 times!
GliSODin - superoxide dismutase from IsoCell, France


Indications for Use
Hyperpigmentation
- Melasma
- Chloasma
- Ultraviolet-induced hyperpigmentation
- Photodermatosis
Reducing inflammation and oxidative DNA damage
- Prevention of hyperpigmentation after laser treatments
- Adjuvant (enhancer) in the treatment of vitiligo
- Anti-aging action
- Chronic Fatigue Syndrome
What is superoxide dismutase?
Superoxide dismutase is the most powerful antioxidant enzyme in the human body, which is responsible for neutralizing free radicals. In inflammatory processes, the balance between damage and repair shifts towards cell damage. Superoxide dismutase shifts this balance towards cell repair, which has a powerful anti-inflammatory effect.

Superoxide dismutase is not absorbed in our body, only thanks to the complex with gliadin in GliSODin it becomes possible.
Venus Clinic is already using this novelty for the treatment of melasma.